Market Size of US Pharmaceutical Contract Packaging Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 8.78 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
US Pharmaceutical Contract Packaging Market Analysis
The United States Pharmaceutical Contract Packaging Market is expected to grow at a CAGR of 8.78% during the forecast period. The packaging of drugs and other medicines plays an essential part in solving these issues. In that regard, pharmaceutical vials are increasingly being administered to ensure that patients take medicine at the inappropriate dosage and at the prescribed time. Besides, products in such form also provide ease of medication intake by the patients. This may help reduce their time of recovery and the burden on the healthcare system.
- Contract packaging gives pharmaceutical companies a chance to differentiate their product against the competition. Differentiation in pharmaceutical packaging is usually focused on the user's needs and use case. For example, the specific indication requirements section is one such need for contract packaging.
- Further, Serialization continues to be a driving factor for flexible, sterile packaging used for medical equipment, devices, implantable devices, and consumables, such as vials and syringes, among others. Increased demand for administering oral drugs, prescription dose medicines, and over-the-counter (OTC) medicines is expected to increase the use of flexible aluminum foil in the pharmaceutical sector.
- Furthermore, according to IQVIA, a human data science company, pharmaceutical sales worldwide are anticipated to reach USD 1.5 trillion in 2023 from USD 491 billion in 2019. The United States dominates the pharmaceutical sector, both in consumption and development. According to STAT, prescription drug spending in the nation is considered to add up to USD 600 billion by 2023, up from an estimated USD 500 billion in 2019.
- Manufacturers in the sector rushed their resources and pushed for quicker manufacturing and packaging procedures as a result of COVID-19's considerable impact on the demand for vials, medications, and other products. Due to supply chain issues in the Asia-Pacific region, which holds a prominent position when it comes to pharmaceutical raw materials as well as packaging industry raw materials, there was a significant shortage of materials for both CMOs and CPOs in the market during the early months of the pandemic, which caused slower manufacturing and packaging.
US Pharmaceutical Contract Packaging Industry Segmentation
The United States is one of the largest regions for the pharmaceutical contract packaging industry because of its large pharmaceutical manufacturing base and the ability to introduce technological advancements to pharmaceutical packaging.
The United States Pharmaceutical Contract Packaging Market is segmented by Service Type ( Primary (Medical Pouches, Blister Packs, Cartridges and Syringes, Vials, Ampoules, Bottles), Secondary, Tertiary), and Material Type (Plastic, Paper & Paperboard, Glass). The market study is focused on the trends affecting the market in the United States. The study tracks the key market parameters, underlying growth influencers, and major vendors operating in the industry. The study tracks the impact of COVID-19 on the overall pharmaceutical packaging industry and its performance. The market sizes and forecasts are provided in terms of value (USD million) for all the segments.
| Service Type | ||||||||
| ||||||||
| Secondary | ||||||||
| Tertiary |
| Material Type | |
| Plastic | |
| Paper & Paperboard | |
| Glass |
US Pharmaceutical Contract Packaging Market Size Summary
The United States Pharmaceutical Contract Packaging Market is poised for significant growth, driven by the increasing need for efficient and differentiated packaging solutions in the pharmaceutical industry. This market is characterized by the rising demand for flexible and sterile packaging, particularly for medical devices and consumables like vials and syringes. The emphasis on serialization and the need for packaging that meets specific user requirements are key factors propelling the market forward. The COVID-19 pandemic has further accelerated the demand for rapid manufacturing and packaging solutions, highlighting the importance of contract packaging in ensuring timely delivery of life-saving drugs. The acquisition of companies like Pharma Packaging Solutions by Tjoapack underscores the strategic moves within the industry to enhance global leadership in contract packaging and supply chain services.
Blister packaging is gaining traction in the United States, driven by the need for barrier protection and longer shelf life for pharmaceutical products. The implementation of FDA regulations mandating unit-dose formats has also contributed to the increased adoption of blister packs. The US pharmaceutical market, being a major player globally, is witnessing a surge in demand for packaging solutions that ensure drug safety and effectiveness. This competitive landscape is marked by strategic acquisitions and collaborations among key players, such as KD Pharma Group's acquisition of Rohner AG and West Pharmaceutical Service's partnership with Corning Incorporated. These developments reflect the industry's focus on expanding market presence and enhancing packaging technologies to meet the evolving needs of the pharmaceutical sector.
US Pharmaceutical Contract Packaging Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Industry Attractiveness-Porter's Five Forces Analysis
-
1.2.1 Bargaining Power of Suppliers
-
1.2.2 Bargaining Power of Buyers/Consumers
-
1.2.3 Threat of New Entrants
-
1.2.4 Threat of Substitute Products
-
1.2.5 Intensity of Competitive Rivalry
-
-
1.3 Assessment of COVID-19 Impact on the market
-
1.4 Market Drivers
-
1.4.1 Cost-Effectiveness Of The Outsourcing
-
1.4.2 Access to the advanced technologies and expertise
-
-
1.5 Market Restraints
-
1.5.1 Monitoring issues and lack of standardization
-
-
-
2. MARKET SEGMENTATION
-
2.1 Service Type
-
2.1.1 Primary
-
2.1.1.1 Medical Pouches
-
2.1.1.2 Blister Packs
-
2.1.1.3 Cartridges and Syringes
-
2.1.1.4 Vials
-
2.1.1.5 Ampoules
-
2.1.1.6 Others Product Types
-
-
2.1.2 Secondary
-
2.1.3 Tertiary
-
-
2.2 Material Type
-
2.2.1 Plastic
-
2.2.2 Paper & Paperboard
-
2.2.3 Glass
-
-
US Pharmaceutical Contract Packaging Market Size FAQs
What is the current US Pharmaceutical Contract Packaging Market size?
The US Pharmaceutical Contract Packaging Market is projected to register a CAGR of 8.78% during the forecast period (2024-2029)
Who are the key players in US Pharmaceutical Contract Packaging Market?
Thermo-Pak Co., Inc., Aphena Pharma Solutions, Sonic Packaging Industries, Inc., Assemblies Unlimited, Inc. and Action Pak, Inc. are the major companies operating in the US Pharmaceutical Contract Packaging Market.
